CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase I Trial of p28 (NSC745104), a Non-HDM2 Mediated Peptide Inhibitor of p53 Ubiquitination in Pediatric Patients With Recurrent or Progressive CNS Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01975116
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:29.092706+00:00
Published At: 2017-08-07T00:00:00+00:00
Record Updated At: 2017-08-07
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Teratoid Tumor, Atypical", "Choroid Plexus Neoplasms", "Anaplastic Astrocytoma", "Anaplastic Oligodendroglioma", "Brainstem Tumors", "Giant Cell Glioblastoma", "Glioblastoma", "Gliosarcoma", "Medulloblastoma", "Neuroectodermal Tumor, Primitive"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2017-08-07"
protocolSection.identificationModule.nctId: "NCT01975116"
protocolSection.identificationModule.officialTitle: "A Phase I Trial of p28 (NSC745104), a Non-HDM2 Mediated Peptide Inhibitor of p53 Ubiquitination in Pediatric Patients With Recurrent or Progressive CNS Tumors"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.